pre-ipo
Stage
2018
Founded
2
Investors
About
Seaport Therapeutics develops new medicines for patients with depression, anxiety, and other neuropsychiatric disorders using its Glyph™ platform to improve drug delivery to the brain and reduce side effects.
Explore Seaport Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.